Recent Blog Posts

View Post: Effect of perindopril on coronary remodelling: insights from a ...
1 Oct 2007 by Rodriguez-Granillo, GA, de Winter, S.,...  
Arterial remodelling: an independent pathophysiological component of atherosclerotic disease progression and regression. Insights from serial pharmacological intervention trials: Paul Schoenhagen and Ilke Sipahi EHJ 2007 28: 2299-2300. ...
View Blog: European Heart Journal - recent issues - http://eurheartj.oxfordjournals.org/

---

View Post: long-term effect of perindopril on coronary atherosclerosis ...
16 Jul 2007
the perspective study, a substudy of the europa trial, evaluated the effect of perindopril on coronary plaque progression as assessed by quantitative coronary angiography and intravascular ultrasound (ivus)...conclusion: we found no ...
View Blog: Cardiology News - http://www.mdlinx.com/InternalMDLinx/news.cfm?subspec_id=4

---

View Post: stroke risk level in patients with hypertension
8 Sep 2009 by Galih Gumelar Center  
while the research results from pogress (perindopril against recurrent protection study) showed that treatment with perindopril in stroke patients with hypertension can significantly reduce the occurrence of re sroke (risk reduction ...
View Blog: Galih Gumelar Health & Therapy - http://galihgumelartherapi.blogspot.com/

---

View Post: Cardiovascular High-Risk Patients -- Treat to Protect, But Whom ...
26 Mar 2008
Sex related cardiovascular risk stratification based on quantification of atherosclerosis and inflammation. Atherosclerosis. 2007 March 25; [Epub ahead of print]. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating ... Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet. 2003;362:782-788. ...
View Blog: Medscape Public Health & Prevention Headlines - http://www.medscape.com/publichealth

---

View Post: Intensive BP and Glucose-Lowering Additive in Diabetic Patients ...
9 Sep 2008
Patients were randomized in one arm of the study to treatment with a fixed combination of perindopril and indapamide or matching placebo, and in the other arm of the study to either standard glucose control or intensive glucose control, defined as the use of modified-release ... "Glucose gives you atherosclerosis over four, five, or six years, so whatever you do in terms of testing therapeutics, you have to think that you're going to get answers at year six or seven. ...
View Blog: Medscape Nephrology Headlines - http://www.medscape.com/nephrology

---

View Post: does it matter how hypertension is controlled?
30 Dec 2008 by Robert Hawkins  
these agents have been shown to inhibit atherosclerosis in various animal models with hypercholesterolemia and to improve endothelium-dependent vasodilatation in isolated arteries and in patients with vascular disease.12,13 diuretics do ...
View Blog: Health News: Interesting and Relevant - http://interestinghealthnews.blogspot.com/

---

View Post: USPharmacist.com > Pharmacologic Management of Post-Acute Coronary ...
20 Feb 2007
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol. 2006;47:2130-2139. ... Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet. 2003;362:782-788. 16. Yusuf S, Sleight P, ...
View Blog: Untitled - http://www.uspharmacist.com/home/

---

View Post: FDA approves Twynsta® (telmisartan plus amlodipine) a new single ...
18 Oct 2009
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure ...
View Blog: Boehringer Ingelheim RSS-Newsfeed - http://www.boehringer-ingelheim.com/

---

View Post: Risk factor status and vascular events in patients with ...
26 Nov 2007 by Chaturvedi, S., Turan, TN, Lynn, MJ, Kasner,...  
Abbreviations: DM = diabetes mellitus; HDL = high-density lipoprotein; LDL = low-density lipoprotein; MAP = mean arterial pressure; MI = myocardial infarction; PROGRESS = Perindopril Protection Against Recurrent Stroke Study; SBP = systolic blood ... S. P. Waddy, G. Cotsonis, M. J. Lynn, M. R. Frankel, S. Chaturvedi, J. E. Williams, and M. Chimowitz Racial Differences in Vascular Risk Factors and Outcomes of Patients With Intracranial Atherosclerotic Arterial Stenosis ...
View Blog: Neurology recent issues - http://www.neurology.org/

---

View Post: Implementation Science
Full text
A randomized trial to assess ... ...
View Blog: Similar benefits with ACE inhibition in CAD patients were seen in the EURopean trial On Reduction of cardiac events with Perindopril in stable coronary Artery disease (EUROPA)[34] and the Simvastatin/Enalapril Coronary Atherosclerosis

---